论文部分内容阅读
The therapeutic potential of neural stem cells (NSCs) on experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), has been recently suggested; however, the clinical and pathological improvement is limited.To enhance their therapeutic effect, we in the present study transduced bone marrow derived NSCs (BM-NSCs) with Neurotrophin 3 (NT-3), a potent neurotrophic factor that possesses both neuroprotection and immunomodulation capacities, with a novel Tet-on system to control NT-3 expression.